journal article·2024-07

Modified Highly Elastic 3D Nanofiber Embolic Scaffolds for Precise In Situ Embolization Therapy

Pengfei Cai, Lei Cao, Yangfan Ding, Yu Han, Xiao Yu, Jie Cui, Hongsheng Wang, Jinglei Wu, Mohamed EL‐Newehy, Meera Moydeen Abdulhameed, Xiumei Mo, Shoubao Wang, Binbin Sun

Advanced Functional Materials· Volume 34· Issue 27
Publisher page

Abstract

Abstract Transcatheter arterial embolization (TAE) is an effective treatment for hemangiomas or highly vascular tumors. However, conventional embolic agents have limitations such as off‐target embolization, regurgitation, and embolic migration, which can affect the efficacy and safety of embolic therapy. The study designed a highly elastic modified embolic scaffold constructed with Polycaprolactone/Gelatin (PCL/GEL) nanofibers to achieve precise in situ embolization in vivo. The embolic scaffolds can be extruded to a small size for smooth intervention in the vessel and rapidly regain their volume when reaching the target area. The results of the in vitro study indicate that the embolic scaffolds modified with lysine and PEI exhibit good biocompatibility and functionality. Furthermore, the in vivo rabbit ear embolization test demonstrated that the modified embolic scaffolds fit closely to the vessels and induced a significant amount of neo tissue deposition in the embolized area. The embolization process using the modified embolic scaffolds is safe and stable and results in more desirable embolization outcomes compared to commercial gelatin embolic agents. In conclusion, the modified highly elastic embolic scaffolds designed in this study offer a novel method for in situ embolization that has potential for clinical application in TAE.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Vascular Malformations Diagnosis and Treatment · Intracranial Aneurysms: Treatment and Complications · Vascular Anomalies and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory for Modification of Chemical Fibers and Polymer Materials Shanghai Engineering Research Center of Nano‐Biomaterials and Regenerative Medicine College of Biological Science and Medical Engineering Donghua University Shanghai 201620 China

Orthopaedic Traumatology, Trauma Center, Shanghai General Hospital, School of Medicine Shanghai Jiao Tong University Shanghai 201620 China

Department of Orthopaedics The First Affiliated Hospital of Zhengzhou University Zhengzhou 450052 China

Department of Chemistry College of Science King Saud University P.O. Box 2455 Riyadh 11451 Saudi Arabia

Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital Shanghai Jiao Tong University School of Medicine Shanghai 200011 China

Funding

Fundamental Research Funds for the Central Universities · National Natural Science Foundation of China · Science and Technology Commission of Shanghai Municipality

References (44)

Show source-provided references
1. Monsignore L. M. · Diagn. Interv. Radiol. · 2011 · 18 · 403
2. 10.1016/j.jconrel.2016.02.03310.1016/j.jconrel.2016.02.033 ↗
3. 10.1007/s00270-010-9863-510.1007/s00270-010-9863-5 ↗
4. Bendszus M. · Am. J. Neuroradiol. · 2000 · 21 · 255
5. 10.1177/000331971770050310.1177/0003319717700503 ↗
6. 10.1002/adfm.20170596210.1002/adfm.201705962 ↗
7. 10.1002/adma.20200560310.1002/adma.202005603 ↗
8. 10.1002/adfm.20191019710.1002/adfm.201910197 ↗
9. 10.1002/adfm.20230520510.1002/adfm.202305205 ↗
10. 10.1016/j.biomaterials.2023.12232410.1016/j.biomaterials.2023.122324 ↗
11. 10.1002/adfm.20230515310.1002/adfm.202305153 ↗
12. 10.1002/adfm.20201117010.1002/adfm.202011170 ↗
13. 10.1002/adma.20190107110.1002/adma.201901071 ↗
14. 10.1016/j.biomaterials.2022.12163410.1016/j.biomaterials.2022.121634 ↗
15. 10.31083/j.fbl280406610.31083/j.fbl2804066 ↗
16. 10.1016/j.progpolymsci.2013.06.00210.1016/j.progpolymsci.2013.06.002 ↗
17. 10.1021/acsami.6b0682510.1021/acsami.6b06825 ↗
18. 10.1002/adfm.20221123710.1002/adfm.202211237 ↗
19. 10.1002/adhm.20210091810.1002/adhm.202100918 ↗
20. 10.1021/acs.nanolett.9b0431310.1021/acs.nanolett.9b04313 ↗
21. 10.1002/SMMD.2023002410.1002/SMMD.20230024 ↗
22. 10.1021/acs.chemmater.0c0203010.1021/acs.chemmater.0c02030 ↗
23. 10.1002/adma.20230586810.1002/adma.202305868 ↗
24. 10.1148/radiol.202120250010.1148/radiol.2021202500 ↗
25. 10.1016/j.pmatsci.2021.10087110.1016/j.pmatsci.2021.100871 ↗
26. 10.1021/acsnano.6b0412410.1021/acsnano.6b04124 ↗
27. 10.1021/bm300938910.1021/bm3009389 ↗
28. 10.1002/anie.20161211210.1002/anie.201612112 ↗
29. 10.1038/srep3214510.1038/srep32145 ↗
30. 10.1016/j.cej.2021.13197710.1016/j.cej.2021.131977 ↗
31. 10.1002/adhm.20210228110.1002/adhm.202102281 ↗
32. 10.3389/fbioe.2023.112876210.3389/fbioe.2023.1128762 ↗
33. 10.1016/j.cej.2019.12298610.1016/j.cej.2019.122986 ↗
34. 10.1021/acsami.3c1242610.1021/acsami.3c12426 ↗
35. 10.1002/jbm.a.3743510.1002/jbm.a.37435 ↗
36. Ma X. · ACS Appl. Mater. Interfaces · 2021 · 3 · 6586
37. 10.1002/jbm.b.3469210.1002/jbm.b.34692 ↗
38. 10.1002/adma.20170033910.1002/adma.201700339 ↗
39. 10.1093/rb/rbad01910.1093/rb/rbad019 ↗
40. 10.1016/j.biomaterials.2019.03.00810.1016/j.biomaterials.2019.03.008 ↗
41. 10.1021/acsami.5b1271510.1021/acsami.5b12715 ↗
42. 10.1016/j.actbio.2020.07.04310.1016/j.actbio.2020.07.043 ↗
43. 10.1016/j.biomaterials.2020.12028810.1016/j.biomaterials.2020.120288 ↗
44. 10.1002/smll.20190342110.1002/smll.201903421 ↗